Targeting of severe fever with thrombocytopenia syndrome virus structural proteins to the ERGIC (endoplasmic reticulum Golgi intermediate compartment) and Golgi complex

Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus glycoproteins (GP) play a key role in targeting viral structural components to the budding compartments in the ER–Golgi intermediate compartment (ER...

Full description

Saved in:
Bibliographic Details
Published inBiomedical Research Vol. 39; no. 1; pp. 27 - 38
Main Authors LUNDU, Tapiwa, TSUDA, Yoshimi, ITO, Ryo, SHIMIZU, Kenta, KOBAYASHI, Shintaro, YOSHII, Kentaro, YOSHIMATSU, Kumiko, ARIKAWA, Jiro, KARIWA, Hiroaki
Format Journal Article
LanguageEnglish
Published Japan Biomedical Research Press 01.01.2018
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus glycoproteins (GP) play a key role in targeting viral structural components to the budding compartments in the ER–Golgi intermediate compartment (ERGIC) and Golgi complex. However, the role of SFTSV GP in targeting structural proteins to the ERGIC and Golgi complex remains unresolved. In this study, we show that SFTSV GP plays a significant role in targeting RNA-dependent RNA polymerase (L) and nucleocapsid protein (NP) to the budding sites. Confocal microscopy was used to investigate the subcellular localization of SFTSV structural proteins. In SFTSV-infected cells, GP and L localized to the ER, ERGIC and Golgi complex, whereas NP localized to the ERGIC and Golgi complex. In addition, GP colocalized with L and NP in infected cells. In cells singly transfected with GP, L or NP, GP localized to the same subcellular compartments as in infected cells. However, L or NP alone did not localize to the ER, ERGIC, or Golgi complex. Cotransfection experiments showed that GP altered the localization of L to the ERGIC and Golgi complex but not that of NP. Interestingly, plasmid-expressed NP fused with a hemagglutinin tag localized to the ERGIC and Golgi complex when expressed in SFTSV-infected cells and colocalised with GP, suggesting that GP plays a role in the subcellular localization of L and NP in infected cells. Thus, the SFTSV structural components start to assemble at the ERGIC to Golgi complex. GP is required for transporting L and NP to the ERGIC and Golgi complex. In addition, targeting of NP requires interaction with other factors besides GP.
AbstractList Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus glycoproteins (GP) play a key role in targeting viral structural components to the budding compartments in the ER–Golgi intermediate compartment (ERGIC) and Golgi complex. However, the role of SFTSV GP in targeting structural proteins to the ERGIC and Golgi complex remains unresolved. In this study, we show that SFTSV GP plays a significant role in targeting RNA-dependent RNA polymerase (L) and nucleocapsid protein (NP) to the budding sites. Confocal microscopy was used to investigate the subcellular localization of SFTSV structural proteins. In SFTSV-infected cells, GP and L localized to the ER, ERGIC and Golgi complex, whereas NP localized to the ERGIC and Golgi complex. In addition, GP colocalized with L and NP in infected cells. In cells singly transfected with GP, L or NP, GP localized to the same subcellular compartments as in infected cells. However, L or NP alone did not localize to the ER, ERGIC, or Golgi complex. Cotransfection experiments showed that GP altered the localization of L to the ERGIC and Golgi complex but not that of NP. Interestingly, plasmid-expressed NP fused with a hemagglutinin tag localized to the ERGIC and Golgi complex when expressed in SFTSV-infected cells and colocalised with GP, suggesting that GP plays a role in the subcellular localization of L and NP in infected cells. Thus, the SFTSV structural components start to assemble at the ERGIC to Golgi complex. GP is required for transporting L and NP to the ERGIC and Golgi complex. In addition, targeting of NP requires interaction with other factors besides GP.
Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus glycoproteins (GP) play a key role in targeting viral structural components to the budding compartments in the ER-Golgi intermediate compartment (ERGIC) and Golgi complex. However, the role of SFTSV GP in targeting structural proteins to the ERGIC and Golgi complex remains unresolved. In this study, we show that SFTSV GP plays a significant role in targeting RNA-dependent RNA polymerase (L) and nucleocapsid protein (NP) to the budding sites. Confocal microscopy was used to investigate the subcellular localization of SFTSV structural proteins. In SFTSV-infected cells, GP and L localized to the ER, ERGIC and Golgi complex, whereas NP localized to the ERGIC and Golgi complex. In addition, GP colocalized with L and NP in infected cells. In cells singly transfected with GP, L or NP, GP localized to the same subcellular compartments as in infected cells. However, L or NP alone did not localize to the ER, ERGIC, or Golgi complex. Cotransfection experiments showed that GP altered the localization of L to the ERGIC and Golgi complex but not that of NP. Interestingly, plasmid-expressed NP fused with a hemagglutinin tag localized to the ERGIC and Golgi complex when expressed in SFTSV-infected cells and colocalised with GP, suggesting that GP plays a role in the subcellular localization of L and NP in infected cells. Thus, the SFTSV structural components start to assemble at the ERGIC to Golgi complex. GP is required for transporting L and NP to the ERGIC and Golgi complex. In addition, targeting of NP requires interaction with other factors besides GP.Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus glycoproteins (GP) play a key role in targeting viral structural components to the budding compartments in the ER-Golgi intermediate compartment (ERGIC) and Golgi complex. However, the role of SFTSV GP in targeting structural proteins to the ERGIC and Golgi complex remains unresolved. In this study, we show that SFTSV GP plays a significant role in targeting RNA-dependent RNA polymerase (L) and nucleocapsid protein (NP) to the budding sites. Confocal microscopy was used to investigate the subcellular localization of SFTSV structural proteins. In SFTSV-infected cells, GP and L localized to the ER, ERGIC and Golgi complex, whereas NP localized to the ERGIC and Golgi complex. In addition, GP colocalized with L and NP in infected cells. In cells singly transfected with GP, L or NP, GP localized to the same subcellular compartments as in infected cells. However, L or NP alone did not localize to the ER, ERGIC, or Golgi complex. Cotransfection experiments showed that GP altered the localization of L to the ERGIC and Golgi complex but not that of NP. Interestingly, plasmid-expressed NP fused with a hemagglutinin tag localized to the ERGIC and Golgi complex when expressed in SFTSV-infected cells and colocalised with GP, suggesting that GP plays a role in the subcellular localization of L and NP in infected cells. Thus, the SFTSV structural components start to assemble at the ERGIC to Golgi complex. GP is required for transporting L and NP to the ERGIC and Golgi complex. In addition, targeting of NP requires interaction with other factors besides GP.
Author KARIWA, Hiroaki
LUNDU, Tapiwa
YOSHII, Kentaro
SHIMIZU, Kenta
ARIKAWA, Jiro
TSUDA, Yoshimi
YOSHIMATSU, Kumiko
ITO, Ryo
KOBAYASHI, Shintaro
Author_xml – sequence: 1
  fullname: LUNDU, Tapiwa
  organization: Laboratory of Public Health, Department of Preventive Veterinary Science, Division of Veterinary Medicine, Graduate School of Veterinary Medicine, Hokkaido University
– sequence: 2
  fullname: TSUDA, Yoshimi
  organization: Laboratory of Microbiology and Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University
– sequence: 3
  fullname: ITO, Ryo
  organization: Laboratory of Microbiology and Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University
– sequence: 4
  fullname: SHIMIZU, Kenta
  organization: Laboratory of Microbiology and Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University
– sequence: 5
  fullname: KOBAYASHI, Shintaro
  organization: Laboratory of Public Health, Department of Preventive Veterinary Science, Division of Veterinary Medicine, Faculty of Veterinary Medicine, Hokkaido University
– sequence: 6
  fullname: YOSHII, Kentaro
  organization: Laboratory of Public Health, Department of Preventive Veterinary Science, Division of Veterinary Medicine, Faculty of Veterinary Medicine, Hokkaido University
– sequence: 7
  fullname: YOSHIMATSU, Kumiko
  organization: Laboratory of Microbiology and Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University
– sequence: 8
  fullname: ARIKAWA, Jiro
  organization: Laboratory of Microbiology and Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University
– sequence: 9
  fullname: KARIWA, Hiroaki
  organization: Laboratory of Public Health, Department of Preventive Veterinary Science, Division of Veterinary Medicine, Faculty of Veterinary Medicine, Hokkaido University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29467349$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtvEzEUhS1URNPCmh2yxKYsJvVjPI8lVKVUqoSEsmBneew7iaMZe7A9hfwjfiaOkkZqJVZXvv7OvT4-F-jMeQcIvadkyRgj1531I5gAccnbJatfoQVtGlJwyn-eoQXhTVNUlNTn6CLGLcln2vA36Jy1ZVXzsl2gvysV1pCsW2Pf4wiPEAD3-4J_27TBaRP82Hm9S34CZxWOO2dyC_CjDXPEMYVZpzmoAU_BJ7Au4uSzDPDtj7v7G3wFzvhpUHG0Goe8Sc_DPOI7P6wtti5ByAasSoC1HycV0ggufcLKmSOzbw_w5y163ashwrtjvUSrr7erm2_Fw_e85vNDoQUVqWCd6I1pVEkaZspSa05rw9u2LkEJRrueQ9N1nHdVR5pacEXbXijDGdOmqgy_RFeHsdnNrxlikqONGoZBOfBzlIyQuqRt1bYZ_fgC3fo5uPw4yVhJeUWFEJn6cKTmLjuVU7CjCjv5FEEGxAHQwccYoJfaJpWsdykoO0hK5D5qeYpa8layOuuuX-ieRv9f8eWg2Mak1nDi86dbPcBznh5Ep0u9UUGC4_8AW6PLtA
CitedBy_id crossref_primary_10_3390_v13010033
crossref_primary_10_3390_vaccines12121403
crossref_primary_10_1080_15548627_2021_1994296
crossref_primary_10_1038_s41598_021_01985_x
crossref_primary_10_1099_jgv_0_001845
crossref_primary_10_3390_microorganisms11092309
crossref_primary_10_46234_ccdcw2023_132
crossref_primary_10_3390_v12090958
crossref_primary_10_1128_JVI_00308_19
crossref_primary_10_3389_fimmu_2021_676861
crossref_primary_10_1016_j_chembiol_2024_10_009
Cites_doi 10.1128/JVI.71.2.1162-1172.1997
10.1371/journal.pone.0166013
10.1073/pnas.1113643108
10.1093/infdis/jit603
10.1016/j.chom.2013.10.010
10.1128/JVI.71.6.4717-4727.1997
10.1097/MD.0000000000002533
10.1128/JVI.06192-11
10.1128/JVI.77.2.1368-1381.2003
10.1128/JVI.00110-16
10.7883/yoken.JJID.2016.357
10.1099/vir.0.80671-0
10.1016/j.virol.2013.09.023
10.1128/JVI.02655-06
10.1371/journal.pone.0080802
10.1128/JVI.00418-07
10.7883/yoken.67.423
10.1096/fj.13-243857
10.1128/JVI.78.19.10793-10802.2004
10.1371/journal.pone.0165207
10.1128/JVI.79.17.10852-10863.2005
10.3390/v8050143
10.1128/JVI.76.23.12200-12210.2002
10.1128/JVI.00767-07
10.1371/journal.pone.0018070
10.1016/S1473-3099(14)70718-2
10.1056/NEJMoa1203378
10.2220/biomedres.38.89
10.3201/eid2110.141928
10.1016/j.virol.2006.12.038
10.3390/v7041700
10.1007/s11427-013-4518-9
10.1007/s00705-017-3358-5
ContentType Journal Article
Copyright 2018 Biomedical Research Press
Copyright Japan Science and Technology Agency 2018
Copyright_xml – notice: 2018 Biomedical Research Press
– notice: Copyright Japan Science and Technology Agency 2018
DBID AAYXX
CITATION
NPM
7QO
7QP
8FD
FR3
K9.
P64
RC3
7X8
DOI 10.2220/biomedres.39.27
DatabaseName CrossRef
PubMed
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Biotechnology Research Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1880-313X
EndPage 38
ExternalDocumentID 29467349
10_2220_biomedres_39_27
article_biomedres_39_1_39_27_article_char_en
Genre Journal Article
GroupedDBID ---
.55
23N
2WC
5GY
ACIWK
ACPRK
ADBBV
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
M~E
OK1
P2P
PQEST
PQQKQ
RJT
RNS
RZJ
TR2
X7M
.GJ
3O-
53G
AAYXX
AI.
CITATION
OVT
TKC
VH1
ZGI
NPM
7QO
7QP
8FD
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c515t-2b5fdd8a4082d44cc317d39974ea521bf3e8bb33b6b08753a19f5ad322cd66d3
ISSN 0388-6107
1880-313X
IngestDate Fri Jul 11 12:32:45 EDT 2025
Mon Jun 30 09:58:02 EDT 2025
Wed Feb 19 02:42:20 EST 2025
Tue Jul 01 02:53:28 EDT 2025
Thu Apr 24 23:10:23 EDT 2025
Thu Aug 17 20:29:47 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c515t-2b5fdd8a4082d44cc317d39974ea521bf3e8bb33b6b08753a19f5ad322cd66d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/biomedres/39/1/39_27/_article/-char/en
PMID 29467349
PQID 2241361555
PQPubID 1966363
PageCount 12
ParticipantIDs proquest_miscellaneous_2007419699
proquest_journals_2241361555
pubmed_primary_29467349
crossref_citationtrail_10_2220_biomedres_39_27
crossref_primary_10_2220_biomedres_39_27
jstage_primary_article_biomedres_39_1_39_27_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Sapporo
PublicationTitle Biomedical Research
PublicationTitleAlternate Biomed. Res.
PublicationYear 2018
Publisher Biomedical Research Press
Japan Science and Technology Agency
Publisher_xml – name: Biomedical Research Press
– name: Japan Science and Technology Agency
References 11 McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, Batten BC, Albariño CG, Zaki SR, Rollin PE, Nicholson WL and Nichol ST (2012) A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med 367, 834–841.
27 Tani H, Fukuma A, Fukushi S, Taniguchi S, Yoshikawa T, Iwata-Yoshikawa N, Sato Y, Suzuki T, Nagata N, Hasegawa H, Kawai Y, Uda A, Morikawa S, Shimojima M, Watanabe H and Saijo M (2016) Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus. mSphere 1, e00061–15.
17 Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, Barrows NJ, Pearson JL, Thompson J, Kellye DL, Ladungaf I, and Pattnaik AK (2011) RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci 108, 19036–19041.
3 Andersson AM, Melin L, Bean A and Pettersson RF (1997) A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein. J Virol 71, 4717–4727.
18 Piper ME, Sorenson DR and Gerrard SR (2011) Efficient cellular release of Rift Valley fever virus requires genomic RNA. PloS One 6, e18070.
25 Snippe M, Smeenk L, Goldbach R and Kormelink R (2007) The cytoplasmic domain of tomato spotted wilt virus Gn glycoprotein is required for Golgi localisation and interaction with Gc. Virology 363, 272–279.
33 Xu B, Liu L, Huang X, Ma H, Zhang Y, et al. (2011) Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan province, China: Discovery of a new Bunyavirus. PloS Pathog 7, e1002369.
13 Nishio S, Tsuda Y, Ito R, Shimizu K, Yoshimatsu K and Arikawa J (2017) Establishment of subclones of the severe fever with thrombocytopenia syndrome virus YG1 strain selected using low pH-dependent cell fusion activity. Jpn J Infect Dis 70, 388–393.
7 Jäntti J, Hildén P, Rönkä H, Mäkiranta V, Keränen S and Kuismanen E (1997) Immunocytochemical analysis of Uukuniemi virus budding compartments: role of the intermediate compartment and the Golgi stack in virus maturation. J Virol 71, 1162–1172.
12 Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo-Chaigne B, Escriou N, van der Werf S, Yuen KY and Altmeyer R (2005) Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol 86, 1423–1434.
16 Överby AK, Popov VL, Pettersson RF and Neve EPA (2007) The cytoplasmic tails of Uukuniemi virus (Bunyaviridae) GN and GC glycoproteins are important for intracellular targeting and the budding of virus-like particles. J Virol 81, 11381–11391.
35 Zhang X, Liu Y, Zhao L, Li B, Yu H, Wen H and Yu X (2013) An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV. Sci China Life Sci 56, 697–700.
26 Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, et al. (2014) The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis 209, 816–827.
21 Salanueva IJ, Novoa RR, Cabezas P, López-Iglesias C, Carrascosa JL, Elliott RM and Risco C (2003) Polymorphism and structural maturation of Bunyamwera virus in Golgi and post-Golgi compartments. J Virol 77, 1368–81.
29 Tsuda Y, Igarashi M, Ito R, Nishio S, Shimizu K, Yoshimatsu K and Arikawa J (2017) The amino acid at position 624 in the glycoprotein of SFTSV (severe fever with thrombocytopenia virus) plays a critical role in low-pH-dependent cell fusion activity. Biomed Res (Tokyo) 38, 89–97.
9 Klaus JP, Eisenhauer P, Russo J, Mason AB, Do D, King B, Taatjes D, Cornillez-Ty C, Boyson JE, Thali M, Zheng C, Liao L, Yates JR 3rd, Zhang B, Ballif BA and Botten JW (2013) The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles. Cell Host Microbe 14, 522–534.
20 Ramanathan HN, Chung D-H, Plane SJ, Sztul E, Chu Y, Guttieri MC, McDowell M, Ali G and Jonsson CB (2007) Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment. J Virol 81, 8634–8647.
1 Adams MJ, Lefkowitz EJ, King AMQ, Harrach B, Harrison RL, et al. (2017) Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses. Arch Virol 162, 2505–2538.
28 Tani H, Shimojima M, Fukushi S, Yoshikawa T, Fukuma A, Taniguchi S, Morikawa S and Saijo M (2016) Characterization of glycoprotein-mediated entry of severe fever with thrombocytopenia syndrome virus. J Virol 90, 5292–5301.
22 Shi X, Lappin DF and Elliott RM (2004) Mapping the Golgi targeting and retention signal of Bunyamwera virus glycoproteins. J Virol 78, 10793–10802.
2 Albornoz A, Hoffmann A, Lozach PY and Tischler N (2016) Early Bunyavirus-host cell interactions. Viruses 8, 143.
19 Plegge T, Hofmann-Winkler H, Spiegel M and Pöhlmann S (2016) Evidence that processing of the severe fever with thrombocytopenia syndrome virus Gn/Gc polyprotein is critical for viral infectivity and requires an internal Gc signal peptide. PloS One 11, e0166013.
24 Shin J, Kwon D, Youn SK and Park JH (2015) Characteristics and factors associated with death among patients hospitalized for severe fever with thrombocytopenia syndrome, South Korea, 2013. Emerg Infect Dis 21, 1704–1710.
31 Wu X, Qi X, Liang M, Li C, Cardona CJ, Li D and Xing Z (2014) Roles of viroplasm-like structures formed by non structural protein NSs in infection with severe fever with thrombocytopenia syndrome virus. FASEB J 28, 2504–2516.
8 Kato H, Yamagishi T, Shimada T, Matsui T, Shimojima M, Saijo M, Oishi K and SFTS epidemiological research group-Japan (2016) Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013–2014. PloS One 11, e0165207.
10 Liu Q, He B, Huang SY, Wei F and Zhu XQ (2014) Severe fever with thrombocytopenia syndrome, an emerging tickborne zoonosis. Lancet Infect Dis 14, 763–772.
36 Zhang YZ, Zhou DJ, Qin XC, Tian JH, Xiong Y, et al. (2012) The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol 86, 2864–2868.
15 Överby AK, Pettersson RF and Neve EPA (2007) The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J Virol 81, 3198–3205.
34 Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, et al. (2011) Fever with thrombocytopenia associated with a novel Bunyavirus in China. N Engl J Med 364, 1523–1532.
6 Gerrard SR and Nichol ST (2002) Characterization of the Golgi retention motif of Rift Valley fever virus GN glycoprotein. J Virol 76, 12200–12210.
5 Deng B, Zhou B, Zhang S, Zhu Y, Han L, et al. (2013) Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PloS One 8, e80802.
14 Novoa RR, Calderita G, Cabezas P, Elliott RM and Risco C (2005) Key Golgi factors for structural and functional maturation of Bunyamwera virus. J Virol 79, 10852–10863.
23 Shimojima M, Fukushi S, Tani H, Yoshikawa T, Fukuma A, Taniguchi S, Suda Y, Maeda K, Takahashi T, Morikawa S and Saijo M (2014) Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro. Jpn J Infect Dis 67, 423–427.
32 Xing X, Guan X, Liu L, Zhan J, Jiang H, Liu L, Li GM, Xiong JM, Tan L, Xu J, Jiang Y, Yao XM, Zhan F and Nie S (2016) Natural transmission model for severe fever with thrombocytopenia syndrome Bunyavirus in villages of Hubei province, China. Medicine 95, e2533.
30 Ujike M and Taguchi F (2015) Incorporation of spike and membrane glycoproteins into coronavirus virions. Viruses 7, 1700–1725.
4 Carnec X, Ermonval M, Kreher F, Flamand M and Bouloy M (2014) Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis. Virology 448, 1-14.
22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
35
14
36
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 20 Ramanathan HN, Chung D-H, Plane SJ, Sztul E, Chu Y, Guttieri MC, McDowell M, Ali G and Jonsson CB (2007) Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment. J Virol 81, 8634–8647.
– reference: 32 Xing X, Guan X, Liu L, Zhan J, Jiang H, Liu L, Li GM, Xiong JM, Tan L, Xu J, Jiang Y, Yao XM, Zhan F and Nie S (2016) Natural transmission model for severe fever with thrombocytopenia syndrome Bunyavirus in villages of Hubei province, China. Medicine 95, e2533.
– reference: 2 Albornoz A, Hoffmann A, Lozach PY and Tischler N (2016) Early Bunyavirus-host cell interactions. Viruses 8, 143.
– reference: 18 Piper ME, Sorenson DR and Gerrard SR (2011) Efficient cellular release of Rift Valley fever virus requires genomic RNA. PloS One 6, e18070.
– reference: 1 Adams MJ, Lefkowitz EJ, King AMQ, Harrach B, Harrison RL, et al. (2017) Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses. Arch Virol 162, 2505–2538.
– reference: 9 Klaus JP, Eisenhauer P, Russo J, Mason AB, Do D, King B, Taatjes D, Cornillez-Ty C, Boyson JE, Thali M, Zheng C, Liao L, Yates JR 3rd, Zhang B, Ballif BA and Botten JW (2013) The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles. Cell Host Microbe 14, 522–534.
– reference: 34 Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, et al. (2011) Fever with thrombocytopenia associated with a novel Bunyavirus in China. N Engl J Med 364, 1523–1532.
– reference: 5 Deng B, Zhou B, Zhang S, Zhu Y, Han L, et al. (2013) Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PloS One 8, e80802.
– reference: 25 Snippe M, Smeenk L, Goldbach R and Kormelink R (2007) The cytoplasmic domain of tomato spotted wilt virus Gn glycoprotein is required for Golgi localisation and interaction with Gc. Virology 363, 272–279.
– reference: 4 Carnec X, Ermonval M, Kreher F, Flamand M and Bouloy M (2014) Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis. Virology 448, 1-14.
– reference: 14 Novoa RR, Calderita G, Cabezas P, Elliott RM and Risco C (2005) Key Golgi factors for structural and functional maturation of Bunyamwera virus. J Virol 79, 10852–10863.
– reference: 12 Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo-Chaigne B, Escriou N, van der Werf S, Yuen KY and Altmeyer R (2005) Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol 86, 1423–1434.
– reference: 29 Tsuda Y, Igarashi M, Ito R, Nishio S, Shimizu K, Yoshimatsu K and Arikawa J (2017) The amino acid at position 624 in the glycoprotein of SFTSV (severe fever with thrombocytopenia virus) plays a critical role in low-pH-dependent cell fusion activity. Biomed Res (Tokyo) 38, 89–97.
– reference: 8 Kato H, Yamagishi T, Shimada T, Matsui T, Shimojima M, Saijo M, Oishi K and SFTS epidemiological research group-Japan (2016) Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013–2014. PloS One 11, e0165207.
– reference: 26 Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, et al. (2014) The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis 209, 816–827.
– reference: 28 Tani H, Shimojima M, Fukushi S, Yoshikawa T, Fukuma A, Taniguchi S, Morikawa S and Saijo M (2016) Characterization of glycoprotein-mediated entry of severe fever with thrombocytopenia syndrome virus. J Virol 90, 5292–5301.
– reference: 31 Wu X, Qi X, Liang M, Li C, Cardona CJ, Li D and Xing Z (2014) Roles of viroplasm-like structures formed by non structural protein NSs in infection with severe fever with thrombocytopenia syndrome virus. FASEB J 28, 2504–2516.
– reference: 30 Ujike M and Taguchi F (2015) Incorporation of spike and membrane glycoproteins into coronavirus virions. Viruses 7, 1700–1725.
– reference: 11 McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, Batten BC, Albariño CG, Zaki SR, Rollin PE, Nicholson WL and Nichol ST (2012) A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med 367, 834–841.
– reference: 21 Salanueva IJ, Novoa RR, Cabezas P, López-Iglesias C, Carrascosa JL, Elliott RM and Risco C (2003) Polymorphism and structural maturation of Bunyamwera virus in Golgi and post-Golgi compartments. J Virol 77, 1368–81.
– reference: 36 Zhang YZ, Zhou DJ, Qin XC, Tian JH, Xiong Y, et al. (2012) The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol 86, 2864–2868.
– reference: 15 Överby AK, Pettersson RF and Neve EPA (2007) The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J Virol 81, 3198–3205.
– reference: 16 Överby AK, Popov VL, Pettersson RF and Neve EPA (2007) The cytoplasmic tails of Uukuniemi virus (Bunyaviridae) GN and GC glycoproteins are important for intracellular targeting and the budding of virus-like particles. J Virol 81, 11381–11391.
– reference: 23 Shimojima M, Fukushi S, Tani H, Yoshikawa T, Fukuma A, Taniguchi S, Suda Y, Maeda K, Takahashi T, Morikawa S and Saijo M (2014) Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro. Jpn J Infect Dis 67, 423–427.
– reference: 35 Zhang X, Liu Y, Zhao L, Li B, Yu H, Wen H and Yu X (2013) An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV. Sci China Life Sci 56, 697–700.
– reference: 17 Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, Barrows NJ, Pearson JL, Thompson J, Kellye DL, Ladungaf I, and Pattnaik AK (2011) RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci 108, 19036–19041.
– reference: 19 Plegge T, Hofmann-Winkler H, Spiegel M and Pöhlmann S (2016) Evidence that processing of the severe fever with thrombocytopenia syndrome virus Gn/Gc polyprotein is critical for viral infectivity and requires an internal Gc signal peptide. PloS One 11, e0166013.
– reference: 22 Shi X, Lappin DF and Elliott RM (2004) Mapping the Golgi targeting and retention signal of Bunyamwera virus glycoproteins. J Virol 78, 10793–10802.
– reference: 13 Nishio S, Tsuda Y, Ito R, Shimizu K, Yoshimatsu K and Arikawa J (2017) Establishment of subclones of the severe fever with thrombocytopenia syndrome virus YG1 strain selected using low pH-dependent cell fusion activity. Jpn J Infect Dis 70, 388–393.
– reference: 6 Gerrard SR and Nichol ST (2002) Characterization of the Golgi retention motif of Rift Valley fever virus GN glycoprotein. J Virol 76, 12200–12210.
– reference: 33 Xu B, Liu L, Huang X, Ma H, Zhang Y, et al. (2011) Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan province, China: Discovery of a new Bunyavirus. PloS Pathog 7, e1002369.
– reference: 7 Jäntti J, Hildén P, Rönkä H, Mäkiranta V, Keränen S and Kuismanen E (1997) Immunocytochemical analysis of Uukuniemi virus budding compartments: role of the intermediate compartment and the Golgi stack in virus maturation. J Virol 71, 1162–1172.
– reference: 3 Andersson AM, Melin L, Bean A and Pettersson RF (1997) A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein. J Virol 71, 4717–4727.
– reference: 24 Shin J, Kwon D, Youn SK and Park JH (2015) Characteristics and factors associated with death among patients hospitalized for severe fever with thrombocytopenia syndrome, South Korea, 2013. Emerg Infect Dis 21, 1704–1710.
– reference: 10 Liu Q, He B, Huang SY, Wei F and Zhu XQ (2014) Severe fever with thrombocytopenia syndrome, an emerging tickborne zoonosis. Lancet Infect Dis 14, 763–772.
– reference: 27 Tani H, Fukuma A, Fukushi S, Taniguchi S, Yoshikawa T, Iwata-Yoshikawa N, Sato Y, Suzuki T, Nagata N, Hasegawa H, Kawai Y, Uda A, Morikawa S, Shimojima M, Watanabe H and Saijo M (2016) Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus. mSphere 1, e00061–15.
– ident: 7
  doi: 10.1128/JVI.71.2.1162-1172.1997
– ident: 19
  doi: 10.1371/journal.pone.0166013
– ident: 17
  doi: 10.1073/pnas.1113643108
– ident: 26
  doi: 10.1093/infdis/jit603
– ident: 9
  doi: 10.1016/j.chom.2013.10.010
– ident: 3
  doi: 10.1128/JVI.71.6.4717-4727.1997
– ident: 32
  doi: 10.1097/MD.0000000000002533
– ident: 33
– ident: 36
  doi: 10.1128/JVI.06192-11
– ident: 21
  doi: 10.1128/JVI.77.2.1368-1381.2003
– ident: 28
  doi: 10.1128/JVI.00110-16
– ident: 13
  doi: 10.7883/yoken.JJID.2016.357
– ident: 12
  doi: 10.1099/vir.0.80671-0
– ident: 4
  doi: 10.1016/j.virol.2013.09.023
– ident: 15
  doi: 10.1128/JVI.02655-06
– ident: 5
  doi: 10.1371/journal.pone.0080802
– ident: 20
  doi: 10.1128/JVI.00418-07
– ident: 23
  doi: 10.7883/yoken.67.423
– ident: 31
  doi: 10.1096/fj.13-243857
– ident: 22
  doi: 10.1128/JVI.78.19.10793-10802.2004
– ident: 8
  doi: 10.1371/journal.pone.0165207
– ident: 14
  doi: 10.1128/JVI.79.17.10852-10863.2005
– ident: 2
  doi: 10.3390/v8050143
– ident: 6
  doi: 10.1128/JVI.76.23.12200-12210.2002
– ident: 16
  doi: 10.1128/JVI.00767-07
– ident: 18
  doi: 10.1371/journal.pone.0018070
– ident: 34
– ident: 10
  doi: 10.1016/S1473-3099(14)70718-2
– ident: 11
  doi: 10.1056/NEJMoa1203378
– ident: 29
  doi: 10.2220/biomedres.38.89
– ident: 24
  doi: 10.3201/eid2110.141928
– ident: 25
  doi: 10.1016/j.virol.2006.12.038
– ident: 30
  doi: 10.3390/v7041700
– ident: 27
– ident: 35
  doi: 10.1007/s11427-013-4518-9
– ident: 1
  doi: 10.1007/s00705-017-3358-5
SSID ssj0038183
Score 2.1765895
Snippet Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 27
SubjectTerms Compartments
Confocal microscopy
DNA-directed RNA polymerase
Endoplasmic reticulum
Fever
Glycoproteins
Golgi apparatus
Hemagglutinins
Localization
Microscopy
Nucleocapsids
Proteins
RNA polymerase
RNA-directed RNA polymerase
Structural proteins
Thrombocytopenia
Viruses
Title Targeting of severe fever with thrombocytopenia syndrome virus structural proteins to the ERGIC (endoplasmic reticulum Golgi intermediate compartment) and Golgi complex
URI https://www.jstage.jst.go.jp/article/biomedres/39/1/39_27/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/29467349
https://www.proquest.com/docview/2241361555
https://www.proquest.com/docview/2007419699
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Biomedical Research, 2018/02/01, Vol.39(1), pp.27-38
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZCQYgL4k2gICNxKIpS2HdWnBCUlkc5VEEqp5W99jYLzTpKdoH0F3HlHzJje91N1EjAZROtx3Gi-TIznh1_Q8hTCV49FxC5hSx5MQz5iA8597yh9GIehcJPpOYtOPwUH3wO3x9Hx73e707VUlPz3fzswnMl_6NVuAd6xVOy_6BZ96FwA96DfuEKGobr3-lYl3HbumVwcXIuBwW-2PTqZK6mXOXLGntklczREwy-l_NmMTDcsZp3Q9M1YLWMDUX3jvZBPRB9ykqoGUTYU031XJts4WBfnZ6Ummpiro-e1NIWs-uadcw0YD7eSOmidflz5emxPvOv4WHJhia41lh9W6pOauJjU4lGA4rNyh_Of4wXjdAh7xe1mJTT0qFbd4QaHC2VSxvh8Fljzx_VrJvi8EadFIc0ZhmsDHgL3TnY2W1DgrSCT2uEk4t8AwRCWExpWA3gx-3iOaUVSVDubKqh4qfgPwLDpbpGx90OXSKXfdiZYNOMN-8-tM4f45_AMEjhes_XVkPqaTt_JQ668hW2Aidy8y5HRzvjG-S63abQVwZzN0lPVrfI1UNbiHGb_HLQo6qgBnpUQ48i9Og69GgLPaqhR8-hR1vo0VrBNEk19OhOB3jUAY9qSNEu8GgHeM8owM7KWNjdIeO3e-PXB0Pb9GOYQ2hdD30eFUKMGDZCF2GY5xDgCoiik1AyCDV5EcgR50HAY47NGALmpUXEBPilXMSxCO6SrUpV8j6hIWPSz3nE4zyATYGf5ixBfsI4DqMkLZI-2W01kOWWEB_7spxmsDFG7WVOe1mQZj5M2HETZoYLZrPoS6NSJ2iNxKqgZ6TdIJ60BMPWJ9stDjJrbhaZfgKOVQRRnzxxw-AM8Akfq6RqFthTFnYIaZymfXLP4Md9gRZ4DzaOPCTXzv9922QLkCAfQchd88ca5H8AN2blPQ
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+of+severe+fever+with+thrombocytopenia+syndrome+virus+structural+proteins+to+the+ERGIC+%28endoplasmic+reticulum+Golgi+intermediate+compartment%29+and+Golgi+complex&rft.jtitle=Biomedical+research+%28Tokyo%29&rft.au=Lundu%2C+Tapiwa&rft.au=Tsuda%2C+Yoshimi&rft.au=Ito%2C+Ryo&rft.au=Shimizu%2C+Kenta&rft.date=2018-01-01&rft.eissn=1880-313X&rft.volume=39&rft.issue=1&rft.spage=27&rft_id=info:doi/10.2220%2Fbiomedres.39.27&rft_id=info%3Apmid%2F29467349&rft.externalDocID=29467349
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0388-6107&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0388-6107&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0388-6107&client=summon